Inconclusive results from com puted tom ography (CT)-guided transthoracic needle aspiration and biopsy (TNAB) performed for lung lesions presents a clinical dilem m a. The purpose of this study was to determ ine the factors affecting an inconclusive result from a CT guided TNAB, and to evaluate the final outcomes of these inconclusive results. Materials and Methods: The m edical records and radiologic features of 331 patients with lung lesion who received CT guided TNAB were analyzed retrospectively. The results of the TNAB were classified as conclusive (m alignancy or specific benign diagnosis) or inconclusive (nonspecific benign or nondiagnostic). Results: Of the 331 cases, 269 (81.3%) were diagnosed as a malignancy (210) or a specific benign lesion (59) after the first TNAB. The rem aining 62 (18.7% ) were inconclusive. Benign disease, a lesion size ≤15 mm, and morphology of the consolidation type were features significantly correlated with inconclusive results. Of these 62 inconclusive cases a second TNAB was perform ed in 23, and conclusive diagnoses were obtained in 19 (82.6%). Surgery or radiographic follow up was done in other cases. Finally, among the 62 inconclusive results on the first CT guided TNAB, 16 lesions were diagnosed as malignant, 26 were classified as specific benign disease, and the remaining 20 were defined as nonspecific inflam mation. Age over 50 and morphology of a nodule or a mass type were significantly correlated with a malignancy in these 62 cases with inconclusive results on the first TNAB. Conclusion: A final diagnosis of benign disease was significantly higher after the CT guided TNAB was inconclusive for lesions ≤15 mm that had consolidation type m orphology. Despite the application of core biopsy procedures, there continue to be appreciable num bers of inconclusive results after the first CT guided TNAB. A repeat CT guided TNAB had a high diagnostic yield in these cases and therefore should be considered for cases with inconclusive results. (J Lung Cancer 2011;10(2):94 101)
INTRODUCTION
Image guided transthoracic needle aspiration and biopsy (TNAB) is a commonly used invasive technique for tissue diagnosis of a lung lesion of unknown etiology (1, 2) . The sensitivity, specificity and adequacy of tissue sampling for malignant lesions are expected to be more than 75% (3) (4) (5) (6) (7) . The false positive rate and false negative rate are expected to be less than 1% and less than 10%, respectively (8, 9) . Imaging modalities used for TNAB are fluoroscopy, computed tomography (CT) and ultrasound (10, 11) . CT is commonly used for difficult lesions; the use of CT imaging has extended the application of biopsy procedures (12) . CT allows for the visualization of the aspiration or biopsy needle tip within the lesion; in addition, it permits determination of the optimal cutaneous entry point so that transgression of a pleural fissure or puncture of large vessels, bronchi and the esophagus can be Inconclusive Results from CT Guided TNAB 95 avoided. Some studies have found that CT-guided TNAB for small lung lesions can produce a diagnostic yield comparable with larger lesions (13, 14) . In addition, the diagnosis of specific benign diseases can also be made with a high success rate (4, 15) . However, inconclusive results such as nonspecific or nondiagnostic benign results after TNAB are not uncommon and present a clinical dilemma (16, 17) . The clinician must decide whether to proceed to another invasive diagnostic procedure for confirmation of the lesion type or to a more conservative regular imaging follow up with inconclusive results. Many previous studies on TNAB have focused on the diagnostic accuracy of the procedure (2) (3) (4) (5) (6) 13, 14) . However, only a few studies have addressed the dilemma of inconclusive results (16, 18) . The aim of this study was to determine the factors affecting inconclusive results such as nonspecific, benign or nondiagnostic results after CT-guided TNAB and to evaluate the final outcome of these inconclusive results.
MATERIALS AND METHODS

1) Study population
Between June 2003 and August 2005, 337 consecutive patients had a CT-guided TNAB for tissue diagnosis of lung lesions at our hospital. We retrospectively reviewed the medical records, radiological images and pathology reports of these cases. Of the 337 patients who had a TNAB during the study period, a final diagnosis was made in 331, and six were lost to follow up. The final analysis included 331 cases. The study was approved by our institutional review board committee, and our committee does not require informed consent from individual patients in a retrospective study like this.
2) CT guided TNAB protocol
Two thoracic radiologists performed the CT-guided TNAB; they had eight and 12 years of experience in thoracic radiology.
The biopsies were performed under CT guidance using an MX 8000 IDT scanner (Philips Medical Systems, Cleveland, Ohio, USA). At the time of biopsy, selected images of the target lesion were obtained by 3-mm-thick contiguous transverse CT sections. The procedure was performed with the patient in a prone, supine or lateral decubitus position, depending on the location of the lesion. Local anesthesia was administered by means of subcutaneous injection of 1% lidocaine (Xylocaine; Choongwae, Seoul, Korea). After the needle tip's position was confirmed to be in the lesion by CT scanning, aspiration or biopsy was performed with 22-gauge Westcott needles (MD TECH, Gainesville, FL, USA). If the tissue obtained was thought to be insufficient or an additional core biopsy was needed, the core biopsy specimen was obtained with a detachable 18-or 20-gauge automated cutting needle (ACECUT; TSK laboratory, Tochigi, Japan).
3) Classification of lung lesions
The lesion size was determined at the longest diameter of the lesion. The morphology of the lesion was classified as a nodule, a mass, consolidation, a cavitary lesion, or ground glass opacity (GGO) by two radiologists. The pulmonary lesion was diagnosed as a malignancy if the aspiration cytology or biopsy specimen showed malignant cells or was highly suggestive of a malignancy. If no malignant cells were found in the TNAB specimen, the lesions were classified into three groups according to the pathology reports: benign specific, benign non-specific or non-diagnostic (15, 18) . The benign specific diagnosis was used for TNAB results that led to a specific benign diagnosis such as hamartoma or tuberculosis. The benign non-specific diagnosis was used when there were no malignant cells and only inflammatory cells in the TNAB specimen. If the TNAB specimens were inadequate or insufficient for pathology examination, we defined the lesion as non-diagnostic.
4) Determination of final diagnosis
In cases with benign non-specific and non-diagnostic TNAB specimens, the final diagnosis was made according to the the results of other tests such as bronchoscopic washing or biopsy were considered. If the lesion did not provide any specific diagnosis, and the size did not change during the follow up over 24 months or they regressed without treatment, the lesions were diagnosed as nonspecific inflammation.
5) Statistics
Statistical analysis was carried out with SPSS for Windows version 11.0 (SPSS Inc., Chicago, IL, USA). Statistically significant differences were identified using the chi-square test and the Yates correction. When the expected values were less than five, the Fisher's exact test was used. The independent student's t test was also used to compare means. The p-value for significance was set at p＜0.05.
RESULTS
The study population included 221 men and 110 women with Table 1 . Of the 331 cases, 225 were finally diagnosed as malignant and 106 were benign (Table 1) . Of the 210 cases diagnosed as malignant after the first CT-guide TNAB, there was one false positive case that was shown to be tuberculosis after surgical resection. Therefore, a correct conclusive specific diagnosis was made in 268 out of 331 cases by CT guided TNAB. The diagnostic sensitivity and specificity, for the malignant lesions, after the first trial of CT-guided TNAB were 92.9% and 99.1%, respectively. Overall, the diagnostic accuracy (the number of true positives and true negatives among the total number of cases) was 94.9%.
A comparison between cases, where the correct pathologic diagnoses were made or not made after the first CT guided TNAB is presented in Values are presented as number (%) unless otherwise indicated. CT: computed tomography, TNAB: transthoracic needle aspiration and biopsy.
nondiagnostic), is shown in Fig. 2 . Of these 62, 27 were clinically suspected to be a malignancy. Among these 27, a 
DISCUSSION AND CONCLUSION
Our study showed that a correct conclusive diagnosis, either a specific malignant or benign diagnosis, was made in 268 of
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These findings are consistent with those of Yeow et al. (6) Although Wallace et al. (14) reported that small lesions that are 10 mm or less had a high diagnostic accuracy rate, most other studies showed a significant increase in diagnostic yield as the lesion size increased (5, 19) . Our study results confirm that CT guided TNAB had a high diagnostic yield for malignant lesions. Most studies have reported that the diagnostic sensitivity for malignant lesions with TNAB is 70∼ 100% (10) . Of the 62 patients with an inconclusive first CT guided TNAB result, 16 were finally diagnosed with a malignancy. This false negative rate was similar to previous reports (16, 18) .
In addition to the diagnosis of a malignant lesion, another important role for the TNAB is diagnosing specific benign disease (16, 17, 20) . The confirmation of a non-malignant lesion makes it possible for patients to avoid unnecessary surgery.
Prior studies reported a remarkably high success rate for a specific diagnosis of benign disease after a transthoracic core biopsy (4, 15, 21, 22) . We also performed core biopsy for diagnosis of benign disease in a majority of patients. Only 2 among 59 benign specific cases, 1 among 50 benign nonspecific cases, and 1 among 12 nondiagnostic cases had aspiration cytology only. Despite the use of a core biopsy, the diagnostic yield for specific benign disease was lower than in previous reports (4, 15) . Although there were no false negative cases, the sensitivity for benign specific disease was only 55.7%. The reason for this relatively low diagnostic yield for benign specific disease in our study is not clear, but pathology interpretation may play an important role. Hirose et al. (22) reported that 42 of the 48 pneumonia or pneumonia-like lesions were correctly diagnosed by CT guided TNB. In our study, the Twenty subjects were diagnosed with nonspecific inflammation. All of these cases were thought to have benign disease by radiological imaging and clinical judgment. Only one case underwent a second TNAB, which was also inconclusive. This case was finally diagnosed as nonspecific inflammation after long term follow up.
The remaining 19 cases with nonspecific inflammation were finally diagnosed as benign during regular imaging follow up for over 24 months. These findings suggest that if lesions are suspected to be benign, and the results of the TNAB are nonspecific with an adequate specimen, the lesion can be followed at regular intervals as suggested previously (19, 23) .
There are several limitations of our study. Since our study was a retrospective review of the medical record, we cannot exclude subjective decision making by the physician before the TNAB. There were no onsite pathologists during TNAB procedures in our study. Immediate feedback on an incomplete specimen may reduce the incidence of inconclusive TNAB results. The follow up period was not long enough to exclude the possibility of a malignancy in the cases reviewed.
According to recent studies, some lesions with ground glass opacities do not show a size change for a long time, and later are diagnosed as bronchioloalveolar carcinoma or adenocarcinoma (24).
In conclusion, despite the common use of core biopsy, there are appreciable numbers of inconclusive results after the first CT guided TNAB. Benign disease, a lesion size ≤15 mm, and morphology of the consolidation type were features that were significantly correlated with inconclusive results. Repeat TNAB had a high diagnostic yield in these cases, and should be recommended, especially in cases thought to be a malignancy.
